FDA Inspection 864458 — Nicola Longo, M.D., Ph.D.
The FDA completed an inspection of Nicola Longo, M.D., Ph.D. on January 13, 2014 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 13, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Salt Lake City, UT (United States)
Additional Details
Clinical Investigator (CI)